Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy-Reference-Cited by-同舟云学术

Methotrexate, vinblastine, doxorubicin and cisplatin combination regimen as salvage chemotherapy for patients with advanced or metastatic transitional cell carcinoma after failure of gemcitabine and cisplatin chemotherapy

Published:2007-12-18 Issue:1 Volume:98 Page:86-90
ISSN:0007-0920
Container-title:British Journal of Cancer
language:en
Short-container-title:Br J Cancer

Author:

Han K S,Joung J Y,Kim T S,Jeong I G,Seo H K,Chung J,Lee K H

Publisher

Springer Science and Business Media LLC

Subject

Cancer Research,Oncology

Link

http://www.nature.com/articles/6604113.pdf

Reference27 articles.

1. Bamias A, Tiliakos I, Karali MD, Dimopoulos MA (2006) Systemic chemotherapy in inoperable or metastatic bladder cancer. Ann Oncol 17: 553–561

2. Bellmunt J, Cos J, Clèries R, Pérez M, Ribas A, Eres N, Murio JE, Margarit C, Baselga J (2002) Feasibility trial of methotrexate–paclitaxel as a second line therapy in advanced urothelial cancer. Cancer Invest 20: 673–685

3. Bellmunt J, Ribas A, Eres N, Albanell J, Almanza C, Bermejo B, Sole LA, Baselga J (1997) Carboplatin-based versus cisplatin-based chemotherapy in the treatment of surgically incurable advanced bladder carcinoma. Cancer 80: 1966–1972

4. Culine S (2002) The present and future of combination chemotherapy in bladder cancer. Semin Oncol 29: 32–39

5. Culine S, Theodore C, De Santis M, Bui B, Demkow T, Lorenz J, Rolland F, Delgado FM, Longerey B, James N (2006) A phase II study of vinflunine in bladder cancer patients progressing after first-line platinum-containing regimen. Br J Cancer 94: 1395–1401

Cited by 43 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Chitosan-coated magnetic nanorods and nanospheres: physicochemical characterizations and potential as methotrexate carriers for targeted drug delivery;Zeitschrift für Physikalische Chemie;2023-11-30

2. The Future of Antibody–Drug Conjugates in Urothelial Cancer;Advances in Oncology;2023-05

3. Treatment Options for Metastatic Urothelial Carcinoma After First-Line Chemotherapy;Cancer Management and Research;2022-06

4. Treatment of Upper Tract Urothelial Carcinoma;Urologic Oncology;2022

5. Chemotherapeutic Protocols for the Treatment of Genitourinary Cancer;Chemotherapy Protocols and Infusion Sequence;2022